All News

Many women who are diagnosed with breast cancer are concerned about the genetic risk of developing other cancers themselves or of a loved one developing cancer. However, a large amount of those concerns are not being addressed, according to a new study.

The incidence of colorectal cancer has been steadily rising by about 1.5 percent per year for people under 50.

Finding spiritual comfort in the midst of cancer, it can be done.

Some friends meet in unexpected ways. They come into your life during times when you least expect them.

On March 24, Angelina Jolie Pitt added another chapter to her BRCA mutation story, making public her choice to undergo a preventive salpingo-oophorectomy, removal of her ovaries and fallopian tubes to reduce her risk of cancer.

For survivors of colorectal cancer, struggles can include negative body image, persistent gastrointestinal problems and sexual dysfunction—issues that can diminish quality of life and jeopardize relationships.

The PBS documentary on the Pulitzer-Prize winning book leaves out important information about the role of oncology nurses.

The value of sharing time with other cancer warriors, talking about what works and doesn't work, and to hear other stories is empowering. You gain a new perspective.

AACR president-elect Nancy Davidson discusses her leadership plans for the organization, as well as precision medicine in oncology, challenges with research funding, and the role of epigenetics in breast cancer.

Treatment with Xtandi reduced the risk of progression by 76 percent compared with bicalutamide in men with castration-resistant prostate cancer, according to topline results from the phase 2 STRIVE study.

A new study has found that although the number of childhood cancer survivors is increasing, the majority of those to survive five or more years beyond diagnosis have at least one chronic health condition.

A partnership between the Pancreatic Cancer Action Network and Perthera, a self-described "concierge" for molecular diagnostic testing, is giving patients with this hard-to-treat cancer the ability to determine the best course of treatment.

The balance between living and living with cancer sometimes comes down to taking short medical breaks just to go on with your day.

It is now well recognized that the presence of a molecular abnormality shown to be actionable in one tumor type may be highly clinically relevant in other malignancies.

In a recent study, researchers looked at statins and survival outcomes, along with potential side effects, in patients with metastatic renal cell carcinoma.

Pretreated patients with recurrent ovarian cancer had a 2.5-month progression-free survival benefit when receiving fosbretabulin plus Avastin compared with Avastin alone; however, hypertension rates doubled.

Eligibility criteria set for coverage of low-dose computed tomography for individuals deemed at high risk for lung cancer may actually exclude many potential lung cancer patients who would benefit from screening, according to a new study.

The Food and Drug Administration (FDA) has approved Jadenu (deferasirox) for the treatment of chronic iron overload, a condition that can affect patients with myelodysplastic syndromes (MDS), sickle cell disease and thalassemia.

The FDA has updated the label for Zytiga plus prednisone to include data that detailed a significant prolongation in overall survival for Zytiga versus placebo in chemotherapy-naive men with metastatic castration-resistant prostate cancer.

The reason breathing techniques are so powerful, is they can lower blood pressure, heart rate and ease tension on capillaries.

Treatment with Avastin plus chemotherapy resulted in an improvement in overall survival of nearly five months compared with chemotherapy alone for women with platinum-sensitive recurrent ovarian cancer.

Treatment with the immunotherapy Vigil delayed time to progression in all patients with stage 3/4 ovarian cancer who were treated with the autologous tumor cell vaccine compared with those who were not, according to an open-label phase 2 trial.

Stomach cancer non-profit organization hosts "Hereditary Diffuse Gastric Cancer: The past, the present, and hope for the future" event.

Diet is precisely where we have the opportunity to provide our bodies with cellular mediators of inflammation.

Cancer is a lonely, confusing experience. Finding others who have walked the path before can be an emotional lifesaver.

Three-time cancer survivor tells about her experience with second opinions.

Jean M. Weigert, head of breast imaging for the Hospital of Central Connecticut, discusses results of a study examining supplemental ultrasound screening in women with dense breast tissue.

Melissa Long knows first-hand what it is like to battle isolation and depression as a teenage cancer survivor.

Oncologist Don Dizon explains the advantages of intraperitoneal therapy and why further research and education are necessary to bring it to the forefront of ovarian cancer treatment.

Elizabeth A. Mittendorf, associate professor of surgical oncology at The University of Texas MD Anderson Cancer Center, discusses the progress and potential of immunotherapy in breast cancer treatment.